Abbott Labs Surges 10% After Strong Q2 Earnings, Analyst Upswing, and Call‑Option Boom
Abbott Laboratories’ 10% rally: earnings beat, TD Cowen buy‑rating, and a spike in call options signal bullish momentum in healthcare equipment and supplies.
4 minutes to read